Abstract
This brief account of a patient severely affected with familial hypercholesterolemia and with coronary artery disease since age 13 reviews his therapy and survival into the fifth decade of life. This is heretofore unreported in phenotypically homozygous patients with familial hypercholesterolemia in the era before statin drugs, low-density lipoprotein apheresis, or their combination.
Copyright 2004 Excerpta Medica, Inc.
MeSH terms
-
Adult
-
Age Factors
-
Blood Component Removal / methods
-
Coronary Artery Bypass / methods
-
Coronary Artery Disease / etiology
-
Coronary Artery Disease / therapy*
-
Humans
-
Hyperlipoproteinemia Type II / complications
-
Hyperlipoproteinemia Type II / genetics*
-
Hyperlipoproteinemia Type II / therapy*
-
Hypolipidemic Agents / therapeutic use
-
Male
-
Obesity / complications
-
Pedigree
-
Severity of Illness Index
-
Survivors
-
Treatment Outcome